Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lioger, Bertrand; Maillot, François; Ternant, David; Passot, Christophe; Paintaud, Gilles; Bejan-Angoulvant, Theodora.
; 204: 225-233.e8, 2019 01.
Artigo em Inglês | MEDLINE | ID: mdl-30314658
Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment.
[Clinical effect of anti-D immunoglobulin in treatment of childhood immune thrombocytopenia: a Meta analysis].
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME).
Comparison of intravenous immune globulin and high dose anti-D immune globulin as initial therapy for childhood immune thrombocytopenic purpura.
International collaborative study to establish immunoglobulin (anti-D test) BRP batch 1.
Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.
The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
Management of severe refractory thrombocytopenia in dengue hemorrhagic fever with intravenous anti-D immune globulin.
Immune regulation by B cells and antibodies a view towards the clinic.
Early plasmapheresis followed by high-dose Î³-globulin treatment saved a severely Rho-incompatible pregnancy.